FDA Inspection
N.Y.S. Psychiatric Institute IRBN.Y.S. Psychiatric Institute IRB – FDA Inspection, Feb 2, 2023
Record Details
This FDA Inspection record concerns N.Y.S. Psychiatric Institute IRB, with an inspection on February 2, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7cffd44d-21ef-411f-bf15-219d38e8f31a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1196560
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 56.108(c)Members present for review
- 21 CFR 50.25(c)ClincialTrials.gov statement
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.108(b)(1)Prompt reporting of unanticipated problems
- 21 CFR 56.110(b)(2)Minor changes
- 21 CFR 50.25(c)ClincialTrials.gov statement
- 21 CFR 56.108(b)(1)Prompt reporting of unanticipated problems
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.108(c)Members present for review
- 21 CFR 56.110(b)(2)Minor changes
Full citation text and observation details available on the Dashboard.
Other FDA inspections of N.Y.S. Psychiatric Institute IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for N.Y.S. Psychiatric Institute IRB
- FDA Inspection 729975 - 2011-06-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.